Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate

被引:4
|
作者
Udali, Silvia [1 ]
De Santis, Domenica [1 ]
Mazzi, Filippo [1 ]
Moruzzi, Sara [1 ]
Ruzzenente, Andrea [2 ]
Castagna, Annalisa [1 ]
Pattini, Patrizia [1 ]
Beschin, Greta [1 ]
Franceschi, Antonia [3 ]
Guglielmi, Alfredo [2 ]
Martinelli, Nicola [1 ]
Pizzolo, Francesca [1 ]
Ambrosani, Francesca [1 ]
Olivieri, Oliviero [1 ]
Choi, Sang-Woon [4 ,5 ]
Friso, Simonetta [1 ]
机构
[1] Univ Verona, Dept Med, Verona, Italy
[2] Univ Verona, Dept Surg, Verona, Italy
[3] Univ Verona, Dept Diagnost & Publ Hlth, Sch Med, Verona, Italy
[4] CHA Univ, Chaum Life Ctr, Sch Med, Seoul, South Korea
[5] Univ Massachusetts, Dept Nutr, Sch Publ Hlth & Hlth Sci, Amherst, MA USA
来源
FRONTIERS IN ONCOLOGY | 2021年 / 10卷
关键词
copper; DNA methylation; epigenetics; hepatocellular carcinoma; MT1G; MT1H; survival rate; trace elements; COPPER; TOXICITY; ZINC; IRON;
D O I
10.3389/fonc.2020.596040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Mechanisms underlying hepatocellular carcinoma (HCC) development are largely unknown. The role of trace elements and proteins regulating metal ions homeostasis, i.e. metallothioneins (MTs), recently gained an increased interest. Object of the study was to investigate the role of promoter DNA methylation in MTs transcriptional regulation and the possible prognostic significance of serum trace elements in HCC. Methods Forty-nine HCC patients were enrolled and clinically characterized. Cu, Se, and Zn contents were measured by Inductively Coupled Plasma Mass Spectrometry in the serum and, for a subset of 27 patients, in HCC and homologous non-neoplastic liver (N) tissues. MT1G and MT1H gene expression in hepatic tissues was assessed by Real-Time RT-PCR and the specific promoter DNA methylation by Bisulfite-Amplicon Sequencing. Results Patients with Cu serum concentration above the 80(th) percentile had a significantly decreased survival rate (P < 0.001) with a marked increased hazard ratio for mortality (HR 6.88 with 95% CI 2.60-18.23, P < 0.001). Se and Zn levels were significantly lower in HCC as compared to N tissues (P < 0.0001). MT1G and MT1H gene expression was significantly down-regulated in HCC as compared to N tissues (P < 0.05). MTs promoter was hypermethylated in 9 out of the 19 HCC tissues showing MTs down-regulation and methylation levels of three specific CpGs paralleled to an increased mortality rate among the 23 patients analyzed (P = 0.015). Conclusions MT1G and MT1H act as potential tumor suppressor genes regulated through promoter DNA methylation and, together with serum Cu concentrations, be related to survival rate in HCC.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan
    Hui-Chen Wu
    Jing Shen
    Hwai-I Yang
    Wei-Yann Tsai
    Chien-Jen Chen
    Regina M Santella
    World Journal of Hepatology, 2016, (05) : 301 - 306
  • [42] Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction
    Zhang, Cheng
    Ge, Shuang
    Wang, Jun
    Jing, Xiaotong
    Li, Hailing
    Mei, Shuyu
    Zhang, Juan
    Liang, Ke
    Xu, Hui
    Zhang, Xiaoying
    Zhang, Cuijuan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (10) : 1869 - 1877
  • [43] Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma
    Lu, Chang-Yi
    Tsai, Kun-Feng
    Yen, Chia-Jui
    Hsieh, Chueh-Jung
    Peng, Pey-Jey
    Huang, Shao-Chang
    Chuang, Meng-Rong
    Chu, Chi-Jen
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [44] Quantification of Tumor DNA in Serum and Vascular Invasion of Human Hepatocellular Carcinoma
    Nishida, Naoshi
    Arizumi, Tadaaki
    Takita, Masahiro
    Nagai, Tonnoyuki
    Kitai, Satoshi
    Yada, Norihisa
    Hagiwara, Satoru
    Inoue, Tatsuo
    Minami, Yasunori
    Ueshima, Kazuonni
    Sakurai, Toshiharu
    Ida, Hiroshi
    Kudo, Masatoshi
    ONCOLOGY, 2013, 84 : 82 - 87
  • [45] Genome-Wide Profiling of DNA Methylation and Tumor Progression in Human Hepatocellular Carcinoma
    Nishida, Naoshi
    Nishimura, Takafumi
    Nakai, Takuya
    Chishina, Hirokazu
    Arizumi, Tadaaki
    Takita, Masahiro
    Kitai, Satoshi
    Yada, Norihisa
    Hagiwara, Satoru
    Inoue, Tatsuo
    Minami, Yasunori
    Ueshima, Kazuomi
    Sakurai, Toshiharu
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2014, 32 (06) : 658 - 663
  • [46] LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation
    Cheng, Di
    Deng, Junge
    Zhang, Bin
    He, Xiaoyu
    Meng, Zhe
    Li, Guolin
    Ye, Huilin
    Zheng, Shangyou
    Wei, Lusheng
    Deng, Xiaogeng
    Chen, Rufu
    Zhou, Jiajia
    EBIOMEDICINE, 2018, 36 : 159 - 170
  • [47] Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma
    Subat, Sophia
    Mogushi, Kaoru
    Yasen, Mahmut
    Kohda, Takashi
    Ishikawa, Yuichi
    Tanaka, Hiroshi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (03) : 675 - 684
  • [48] Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning
    Dong, Rui-Zhao
    Yang, Xuan
    Zhang, Xin-Yu
    Gao, Ping-Ting
    Ke, Ai-Wu
    Sun, Hui-Chuan
    Zhou, Jian
    Fan, Jia
    Cai, Jia-bin
    Shi, Guo-Ming
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (05) : 3369 - 3374
  • [49] Global analysis of DNA methylation in hepatocellular carcinoma via a whole-genome bisulfite sequencing approach
    Yan, Qian
    Tang, Ying
    He, Fan
    Xue, Jiao
    Zhou, Ruisheng
    Zhang, Xiaoying
    Luo, Huiyan
    Zhou, Daihan
    Wang, Xiongwen
    GENOMICS, 2021, 113 (05) : 3618 - 3634
  • [50] Race, Ethnicity, and Socioeconomic Status Influence the Survival of Patients With Hepatocellular Carcinoma in the United States
    Artinyan, Avo
    Mailey, Brian
    Sanchez-Luege, Nicelio
    Khalili, Joshua
    Sun, Can-Lan
    Bhatia, Smita
    Wagman, Lawrence D.
    Nissen, Nicholas
    Colquhoun, Steven D.
    Kim, Joseph
    CANCER, 2010, 116 (05) : 1367 - 1377